As of 27 May, 2021 the Australian government has agreed to invested over $5 billion into five COVID-19 vaccines and $350 million to support vaccine R&D.
- Pfizer
- AstraZeneca
- Moderna
- Novavax
- COVAX
This huge tax-payer commitment is “justified” because Australia is still under a declared Biosecurity emergency, and South Australia continues in an ever extended “state of emergency” (note to date SA has only had 4 COVID-19 designated deaths in 14 months).
The current vaccines are under TGA Provisional Approval, which is only valid for 2 years, before full approval or failure to be approved is reached. All data that the TGA regulatory body uses to assess safety and efficacy is entirely provided by the sponsor.